Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy.
Guo F, Estévez-Vázquez O, Benedé-Ubieto R, Maya-Miles D, Zheng K, Gallego-Durán R, Rojas Á, Ampuero J, Romero-Gómez M, Philip K, Egbuniwe IU, Chen C, Simon J, Delgado TC, Martínez-Chantar ML, Sun J, Reissing J, Bruns T, Lamas-Paz A, Moral MGD, Woitok MM, Vaquero J, Regueiro JR, Liedtke C, Trautwein C, Bañares R, Cubero FJ, Nevzorova YA. Guo F, et al. Among authors: rojas a. Cancers (Basel). 2021 Dec 31;14(1):192. doi: 10.3390/cancers14010192. Cancers (Basel). 2021. PMID: 35008356 Free PMC article.
Entry of hepatitis C virus into the cell: a therapeutic target.
Del Campo JA, Rojas Á, Romero-Gómez M. Del Campo JA, et al. Among authors: rojas a. World J Gastroenterol. 2012 Sep 7;18(33):4481-5. doi: 10.3748/wjg.v18.i33.4481. World J Gastroenterol. 2012. PMID: 22969220 Free PMC article.
Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism.
Del Campo JA, Ampuero J, Rojas L, Conde M, Rojas A, Maraver M, Millán R, García-Valdecasas M, García-Lozano JR, González-Escribano MF, Romero-Gómez M. Del Campo JA, et al. Among authors: rojas a, rojas l. Aliment Pharmacol Ther. 2013 Jan;37(1):74-80. doi: 10.1111/apt.12113. Epub 2012 Nov 5. Aliment Pharmacol Ther. 2013. PMID: 23121166 Free article.
Metformin inhibits glutaminase activity and protects against hepatic encephalopathy.
Ampuero J, Ranchal I, Nuñez D, Díaz-Herrero Mdel M, Maraver M, del Campo JA, Rojas Á, Camacho I, Figueruela B, Bautista JD, Romero-Gómez M. Ampuero J, et al. Among authors: rojas a. PLoS One. 2012;7(11):e49279. doi: 10.1371/journal.pone.0049279. Epub 2012 Nov 15. PLoS One. 2012. PMID: 23166628 Free PMC article.
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C.
Ampuero J, Jimeno C, Quiles R, Rosales JM, Llerena S, Palomo N, Cordero P, Serrano FJ, Urquijo JJ, Moreno-Planas JM, Ontanilla G, Hernández M, Ortega-Alonso A, Maraver M, Bonacci M, Rojas Á, Figueruela B, Forns X, Andrade RJ, Calleja JL, Diago M, Carmona I, de la Mata M, Buti M, Crespo J, Pascasio JM, Navarro JM, Salmerón J, Romero-Gómez M. Ampuero J, et al. Among authors: rojas a. J Hepatol. 2018 May;68(5):940-948. doi: 10.1016/j.jhep.2017.12.019. Epub 2017 Dec 28. J Hepatol. 2018. PMID: 29288753
Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.
Del Campo JA, García-Valdecasas M, Gil-Gómez A, Rojas Á, Gallego P, Ampuero J, Gallego-Durán R, Pastor H, Grande L, Padillo FJ, Muntané J, Romero-Gómez M. Del Campo JA, et al. Among authors: rojas a. PLoS One. 2018 Jan 31;13(1):e0191805. doi: 10.1371/journal.pone.0191805. eCollection 2018. PLoS One. 2018. PMID: 29385181 Free PMC article.
1,440 results